project id: TCGA-UCEC; case submitter id: TCGA-AX-A2HJ; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 9.1; age at index: 35; days to birth: -13112; ethnicity: not hispanic or latino; gender: female; race: asian; vital status: Alive; year of birth: 1974; age at diagnosis: 13112; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 935.0; figo stage: Stage IC; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 779; initial weight: 140.0; oct embedded: false; preservation method: Unknown; sample id: cced4976-8c11-4910-b5d4-6279be4851be; sample submitter id: TCGA-AX-A2HJ-01A; portion id: f42eaa74-6e93-4c42-b970-4bb92b1b9249; portion submitter id: TCGA-AX-A2HJ-01A-11; slide id: 2581d097-54c6-43ad-9f20-d06b2a1be069; slide submitter id: TCGA-AX-A2HJ-01A-01-TSA; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 70.0; percent tumor nuclei: 90.0; section location: TOP;